3/3
08:03 am
dyn
Dyne Therapeutics (DYN) had its price target lowered by HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Dyne Therapeutics (DYN) had its price target lowered by HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.
3/2
10:01 pm
dyn
Dyne Therapeutics (DYN) was given a new $38.00 price target by Chardan Capital.
Medium
Report
Dyne Therapeutics (DYN) was given a new $38.00 price target by Chardan Capital.
3/2
01:20 pm
dyn
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing [Yahoo! Finance]
Low
Report
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing [Yahoo! Finance]
3/2
01:05 pm
dyn
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
Low
Report
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
3/2
07:42 am
dyn
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/2
07:30 am
dyn
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Medium
Report
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2/25
08:03 am
dyn
Dyne Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Dyne Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/25
07:30 am
dyn
Dyne Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Dyne Therapeutics to Participate in Upcoming Investor Conferences
3/2/2026
07:30 am
DYN
dyne therapeutics, inc.
MISS
Report
8.0%
dyne therapeutics, inc.
5/8/2025
07:30 am
DYN
dyne therapeutics, inc.
MISS
Report
16.7%
dyne therapeutics, inc.
3/6
04:10 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Friedl-Naderer Johanna
Neutral
Report
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Friedl-Naderer Johanna
3/6
04:09 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Kerr Douglas
Low
Report
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Kerr Douglas
3/6
04:08 pm
dyn
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Cox John
Low
Report
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Cox John
3/6
12:58 pm
dyn
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.
Low
Report
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.
3/5
04:06 pm
dyn
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
Low
Report
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
3/2
07:52 am
dyn
Form S-8 Dyne Therapeutics, Inc.
Medium
Report
Form S-8 Dyne Therapeutics, Inc.
3/2
07:36 am
dyn
Form 8-K Dyne Therapeutics, Inc. For: Mar 02
Medium
Report
Form 8-K Dyne Therapeutics, Inc. For: Mar 02
3/2
07:21 am
dyn
Form 10-K Dyne Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K Dyne Therapeutics, Inc. For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register